Key Takeaways
Key players operating in the circulating cell-free tumor DNA are BASF SE, Perstorp Holding AB, Chemoxy International Ltd., and Merck Group. The growing incidence and prevalence of various cancers types globally has propelled the demand for non-invasive diagnostic and monitoring approaches. Circulating cell-free tumor DNA analysis provides an easy and repeatable method for early...
How does the test work?
The fecal calprotectin test works by simply measuring the amount of calprotectin protein in a stool sample. An increased level of calprotectin in stool indicates the presence of inflammation in the gastrointestinal tract. During inflammation in IBD, there is an increased migration of neutrophils to the inflammatory sites in the digestive tract. These neutrophils...
The global PARP Inhibitor Market is estimated to be valued at US$ 6.13 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Parp inhibitor drugs have shown promising results in clinical trials for breast cancer and ovarian cancer...
Growing Demand Rising global prevalence of IBD, increasing awareness regarding fecal calprotectin tests, technological advancements facilitating faster and easier tests, and expanding applications of tests are fueling demand for fecal calprotectin tests worldwide. Additionally, growing geriatric population susceptible to gastrointestinal disorders further aids market growth.Global...